Indication

Visceral leishmaniasis

Visceral leishmaniasis, also known as kala-azar, is a severe, potentially fatal systemic protozoan infection caused by species of the *Leishmania donovani* complex (principally *L. Read more about Visceral leishmaniasis

8 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Visceral leishmaniasis therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Visceral leishmaniasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Visceral leishmaniasis.

Visceral leishmaniasis, also known as kala-azar, is a severe, potentially fatal systemic protozoan infection caused by species of the *Leishmania donovani* complex (principally *L.

donovani* and *L.

infantum*) and transmitted by the bite of infected female phlebotomine sand flies.

The disease primarily targets macrophages within the reticuloendothelial system, causing widespread dissemination to internal organs such as the spleen, liver, and bone marrow.

It classically presents with prolonged irregular fever, significant hepatosplenomegaly, substantial weight loss or cachexia, hypergammaglobulinemia, and pancytopenia resulting from bone marrow infiltration and splenic sequestration.

Personalize your experience

Follow Visceral leishmaniasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it